{"entity":{"type":"insider","cik":"0001666236","url":"/insider/0001666236","json_url":"/insider/0001666236.json","name":"Krognes Steve E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":24,"first":"2020-04-01","last":"2026-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Krognes Steve E.","source":"filing","n_filings":24,"first_seen":"2020-04-01","last_seen":"2026-06-05"}],"transactions":[{"id":6139731,"accession":"0001666236-26-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001666236-26-000018","line_url":"/filing/0001666236-26-000018#line-1","is_derivative":false,"issuer_cik":"0001576280","issuer_name":"Guardant Health, Inc.","issuer_ticker":"GH","issuer_name_source":null,"issuer_url":"/issuer/0001576280","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9294.0,"shares_display":"9,294","price_per_share":132.5072,"price_display":"132.51","price_state":"stated","total_value":1231521.9168,"total_display":"1,231,521.92","total_whole":"1,231,522","shares_owned_after":10222.0,"shares_owned_after_display":"10,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-05","scope":"insider"},{"id":4999757,"accession":"0001714899-25-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-25-000048","line_url":"/filing/0001714899-25-000048#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3339.0,"shares_display":"3,339","price_per_share":20.81,"price_display":"20.81","price_state":"stated","total_value":69484.59,"total_display":"69,484.59","total_whole":"69,485","shares_owned_after":25757.0,"shares_owned_after_display":"25,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-08","scope":"insider"},{"id":4278653,"accession":"0001714899-25-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-25-000002","line_url":"/filing/0001714899-25-000002#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":20.25,"price_display":"20.25","price_state":"stated","total_value":607500.0,"total_display":"607,500.00","total_whole":"607,500","shares_owned_after":29096.0,"shares_owned_after_display":"29,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-31","filed_date":"2025-01-03","scope":"insider"},{"id":2227436,"accession":"0001714899-24-000200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000200","line_url":"/filing/0001714899-24-000200#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":29.03,"price_display":"29.03","price_state":"stated","total_value":870900.0,"total_display":"870,900.00","total_whole":"870,900","shares_owned_after":29096.0,"shares_owned_after_display":"29,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-30","filed_date":"2024-10-02","scope":"insider"},{"id":3007693,"accession":"0001714899-24-000196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000196","line_url":"/filing/0001714899-24-000196#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1727.0,"shares_display":"1,727","price_per_share":23.79,"price_display":"23.79","price_state":"stated","total_value":41085.33,"total_display":"41,085.33","total_whole":"41,085","shares_owned_after":32677.0,"shares_owned_after_display":"32,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":2747152,"accession":"0001714899-24-000156","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-24-000156","line_url":"/filing/0001714899-24-000156","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":22.12226666666667,"price_display":"22.12","price_state":"stated","total_value":663668.0,"total_display":"663,668.00","total_whole":"663,668","shares_owned_after":34504.0,"shares_owned_after_display":"34,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider","n_lines":2},{"id":2747140,"accession":"0001714899-24-000156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000156","line_url":"/filing/0001714899-24-000156#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":688.0,"shares_display":"688","price_per_share":21.79,"price_display":"21.79","price_state":"stated","total_value":14991.52,"total_display":"14,991.52","total_whole":"14,992","shares_owned_after":52620.0,"shares_owned_after_display":"52,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-07-03","scope":"insider"},{"id":2327835,"accession":"0001714899-24-000098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000098","line_url":"/filing/0001714899-24-000098#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92500.0,"shares_display":"92,500","price_per_share":20.5,"price_display":"20.50","price_state":"stated","total_value":1896250.0,"total_display":"1,896,250.00","total_whole":"1,896,250","shares_owned_after":47341.0,"shares_owned_after_display":"47,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-02","scope":"insider"},{"id":2065451,"accession":"0001714899-24-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000062","line_url":"/filing/0001714899-24-000062#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2750.0,"shares_display":"2,750","price_per_share":17.29,"price_display":"17.29","price_state":"stated","total_value":47547.5,"total_display":"47,547.50","total_whole":"47,548","shares_owned_after":139841.0,"shares_owned_after_display":"139,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2227410,"accession":"0001714899-24-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000037","line_url":"/filing/0001714899-24-000037#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3208.0,"shares_display":"3,208","price_per_share":19.43,"price_display":"19.43","price_state":"stated","total_value":62331.44,"total_display":"62,331.44","total_whole":"62,331","shares_owned_after":142591.0,"shares_owned_after_display":"142,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-09","scope":"insider"},{"id":8757225,"accession":"0001714899-23-000132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000132","line_url":"/filing/0001714899-23-000132#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1419.0,"shares_display":"1,419","price_per_share":22.6,"price_display":"22.60","price_state":"stated","total_value":32069.4,"total_display":"32,069.40","total_whole":"32,069","shares_owned_after":145799.0,"shares_owned_after_display":"145,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8344881,"accession":"0001714899-23-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000031","line_url":"/filing/0001714899-23-000031#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2119.0,"shares_display":"2,119","price_per_share":30.1,"price_display":"30.10","price_state":"stated","total_value":63781.9,"total_display":"63,781.90","total_whole":"63,782","shares_owned_after":143002.0,"shares_owned_after_display":"143,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":7882533,"accession":"0001714899-23-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000019","line_url":"/filing/0001714899-23-000019#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1377.0,"shares_display":"1,377","price_per_share":30.88,"price_display":"30.88","price_state":"stated","total_value":42521.76,"total_display":"42,521.76","total_whole":"42,522","shares_owned_after":145121.0,"shares_owned_after_display":"145,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-10","scope":"insider"},{"id":8239737,"accession":"0001714899-23-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000015","line_url":"/filing/0001714899-23-000015#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2970.0,"shares_display":"2,970","price_per_share":28.44,"price_display":"28.44","price_state":"stated","total_value":84466.8,"total_display":"84,466.80","total_whole":"84,467","shares_owned_after":146498.0,"shares_owned_after_display":"146,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":6793699,"accession":"0001714899-22-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000128","line_url":"/filing/0001714899-22-000128#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2253.0,"shares_display":"2,253","price_per_share":33.22,"price_display":"33.22","price_state":"stated","total_value":74844.66,"total_display":"74,844.66","total_whole":"74,845","shares_owned_after":149468.0,"shares_owned_after_display":"149,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-23","scope":"insider"},{"id":6611541,"accession":"0001714899-22-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000041","line_url":"/filing/0001714899-22-000041#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2560.0,"shares_display":"2,560","price_per_share":34.69,"price_display":"34.69","price_state":"stated","total_value":88806.4,"total_display":"88,806.40","total_whole":"88,806","shares_owned_after":120221.0,"shares_owned_after_display":"120,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-15","scope":"insider"},{"id":6230660,"accession":"0001714899-22-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000036","line_url":"/filing/0001714899-22-000036#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1296.0,"shares_display":"1,296","price_per_share":37.0931,"price_display":"37.09","price_state":"stated","total_value":48072.6576,"total_display":"48,072.66","total_whole":"48,073","shares_owned_after":122781.0,"shares_owned_after_display":"122,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":6500228,"accession":"0001714899-22-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000007","line_url":"/filing/0001714899-22-000007#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2225.0,"shares_display":"2,225","price_per_share":44.75,"price_display":"44.75","price_state":"stated","total_value":99568.75,"total_display":"99,568.75","total_whole":"99,569","shares_owned_after":124077.0,"shares_owned_after_display":"124,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":4801657,"accession":"0001714899-21-000084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000084","line_url":"/filing/0001714899-21-000084","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2285.0,"shares_display":"2,285","price_per_share":49.56814004376368,"price_display":"49.57","price_state":"stated","total_value":113263.2,"total_display":"113,263.20","total_whole":"113,263","shares_owned_after":95502.0,"shares_owned_after_display":"95,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-23","scope":"insider","n_lines":2},{"id":4661253,"accession":"0001209191-21-021122","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-021122","line_url":"/filing/0001209191-21-021122","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":61.89126288,"price_display":"61.89","price_state":"stated","total_value":3094563.144,"total_display":"3,094,563.14","total_whole":"3,094,563","shares_owned_after":854416.0,"shares_owned_after_display":"854,416","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-16","scope":"insider","n_lines":4},{"id":5092346,"accession":"0001209191-21-012052","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-012052","line_url":"/filing/0001209191-21-012052","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":65.0942009,"price_display":"65.09","price_state":"stated","total_value":3254710.045,"total_display":"3,254,710.04","total_whole":"3,254,710","shares_owned_after":927316.0,"shares_owned_after_display":"927,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider","n_lines":4},{"id":5145040,"accession":"0001209191-21-011006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-011006","line_url":"/filing/0001209191-21-011006","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3035.0,"shares_display":"3,035","price_per_share":70.33927182866557,"price_display":"70.34","price_state":"stated","total_value":213479.69,"total_display":"213,479.69","total_whole":"213,480","shares_owned_after":97987.0,"shares_owned_after_display":"97,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider","n_lines":2},{"id":4087565,"accession":"0001209191-21-009890","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-009890","line_url":"/filing/0001209191-21-009890","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1448.0,"shares_display":"1,448","price_per_share":74.67855248618784,"price_display":"74.68","price_state":"stated","total_value":108134.544,"total_display":"108,134.54","total_whole":"108,135","shares_owned_after":13405.0,"shares_owned_after_display":"13,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-11","scope":"insider","n_lines":2},{"id":4361775,"accession":"0001209191-21-004504","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-004504","line_url":"/filing/0001209191-21-004504","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":71.4511267,"price_display":"71.45","price_state":"stated","total_value":3572556.335,"total_display":"3,572,556.34","total_whole":"3,572,556","shares_owned_after":985199.0,"shares_owned_after_display":"985,199","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-20","scope":"insider","n_lines":4},{"id":2468483,"accession":"0001209191-20-022241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-022241","line_url":"/filing/0001209191-20-022241#line-1","is_derivative":false,"issuer_cik":"0001666236","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001666236","owner_cik":"0001666236","owner_name":"Krognes Steve E.","owner_display_name":"Krognes Steve E.","owner_url":"/insider/0001666236","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1428.0,"shares_display":"1,428","price_per_share":19.48,"price_display":"19.48","price_state":"stated","total_value":27817.44,"total_display":"27,817.44","total_whole":"27,817","shares_owned_after":1006488.0,"shares_owned_after_display":"1,006,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-30","filed_date":"2020-04-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576280","name":"Guardant Health, Inc.","url":"/issuer/0001576280","role":"Director","n_filings":1,"first_seen":"2026-06-05","last_seen":"2026-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001714899","name":"Denali Therapeutics Inc.","url":"/issuer/0001714899","role":"Director, Officer (CFO and Treasurer)","n_filings":23,"first_seen":"2020-04-01","last_seen":"2025-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001666236","retrieved_at":"2026-08-22T07:37:28+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}